Troglitazone reverses the multiple drug resistance phenotype in cancer cells

Troglitazone reverses the multiple drug resistance phenotype in cancer cells

Gerald F Davies1, Bernhard HJ Juurlink2, Troy AA Harkness11Department of Anatomy and Cell Biology, College of Medicine, University of Saskatchewan, Saskatoon, Canada; 2College of Medicine, Alfaisal University, Riyadh, Kingdom of Saudi ArabiaAbstract: A major problem in treating cancer is the develop...

Full description

Bibliographic Details
Main Authors:	Gerald F Davies, Bernhard HJ Juurlink, Troy AA Harkness
Format:	Article
Language:	English
Published:	Dove Medical Press 2009-03-01
Series:	Drug Design, Development and Therapy
Online Access:	http://www.dovepress.com/troglitazone-reverses-the-multiple-drug-resistance-phenotype-in-cancer-a2960

Similar Items

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
by: Megumi Fujita, et al.
Published: (2017-07-01)

Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1
by: Terra Arnason, et al.
Published: (2015-10-01)

Activation of the Anaphase Promoting Complex Reverses Multiple Drug Resistant Cancer in a Canine Model of Multiple Drug Resistant Lymphoma
by: Terra G. Arnason, et al.
Published: (2022-08-01)

Troglitazone Stimulates the Insulin-induced Tetrahydrobiopterin Synthesis In Vascular Endothelial Cells
by: Ishii Masakazu, et al.
Published: (2000-11-01)

Troglitazone suppresses telomerase activity independently of PPARγ in estrogen-receptor negative breast cancer cells
by: Nguyen Johnny, et al.
Published: (2010-07-01)

Prolonged Effect of Troglitazone (CS-045) on Xenograft Survival of Hybrid Artificial Pancreas
by: Yoshiyuki Kawakami, et al.
Published: (1997-09-01)

Exploiting the predictive power of educated spheroids to detect immune-mediated idiosyncratic drug-induced liver injury: the case of troglitazone
by: Salomé Roux, et al.
Published: (2024-04-01)

Effect of troglitazone on tumor growth and pulmonary metastasis development of the mouse osteosarcoma cell line LM8
by: Kidani Teruki, et al.
Published: (2010-02-01)

Troglitazone-Induced PRODH/POX-Dependent Apoptosis Occurs in the Absence of Estradiol or ERβ in ER-Negative Breast Cancer Cells
by: Sylwia Lewoniewska, et al.
Published: (2021-10-01)

Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
by: Kento Fukano, et al.
Published: (2019-01-01)

Mechanistic Insights into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol
by: Katarina Kores, et al.
Published: (2021-02-01)

Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism.
by: Beiyun Zhou, et al.
Published: (2012-01-01)

The troglitazone derivative EP13 disrupts energy metabolism through respiratory chain complex I inhibition in breast cancer cells and potentiates the antiproliferative effect of glycolysis inhibitors
by: Claire Muller, et al.
Published: (2024-04-01)

Correction: Combined Treatment with Troglitazone and Lovastatin Inhibited Epidermal Growth Factor-Induced Migration through the Downregulation of Cysteine-Rich Protein 61 in Human Anaplastic Thyroid Cancer Cells.
by: Li-Han Chin, et al.
Published: (2017-01-01)

Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer.
by: Gerald Davies, et al.
Published: (2017-01-01)

TFPI1 mediates resistance to doxorubicin in breast cancer cells by inducing a hypoxic-like response.
by: Gerald F Davies, et al.
Published: (2014-01-01)

A Macromolecule Reversing Antibiotic Resistance Phenotype and Repurposing Drugs as Potent Antibiotics
by: Xin Ding, et al.
Published: (2020-09-01)

Reversal of Ovarian Cancer Cell Lines Multidrug Resistance Phenotype by the Association of Apiole with Chemotherapies
by: Carolina Afonso de Lima, et al.
Published: (2020-10-01)

Berberine Maintains the Neutrophil N1 Phenotype to Reverse Cancer Cell Resistance to Doxorubicin
by: Shuhui Zhang, et al.
Published: (2020-01-01)

Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
by: Norris-Cervetto, E, et al.
Published: (2004)

Rapid decline of bacterial drug-resistance in an antibiotic-free environment through phenotypic reversion
by: Anett Dunai, et al.
Published: (2019-08-01)

Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin
by: Frontiers Editorial Office
Published: (2023-12-01)

Application of nanoparticles to reverse multi-drug resistance in cancer
by: Yang Jie, et al.
Published: (2016-10-01)

Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling
by: Jae-Seon Lee, et al.
Published: (2020-09-01)

The drug-resistance to gefitinib in PTEN low expression cancer cells is reversed by irradiation in vitro
by: Zhao Lu-Jun, et al.
Published: (2009-09-01)

Oligonucleotides blocking glucosylceramide synthase expression selectively reverse drug resistance in cancer cells
by: Yong-Yu Liu, et al.
Published: (2004-05-01)

Mitochondrial temperature-responsive drug delivery reverses drug resistance in lung cancer
by: Lifo Ruan, et al.
Published: (2022-07-01)

Drug resistance mechanism and reversal strategy in lung cancer immunotherapy
by: Yishi Xu, et al.
Published: (2023-09-01)

Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma.
by: Chaidos, A, et al.
Published: (2013)

Mechanistic insights into aging, cell cycle progression, and stress response
by: Troy Anthony Alan Harkness
Published: (2012-06-01)

Vitamin D-Induced Molecular Mechanisms to Potentiate Cancer Therapy and to Reverse Drug-Resistance in Cancer Cells
by: Mariarosaria Negri, et al.
Published: (2020-06-01)

Regulation Of Cell Death Apoptotic Pathways By Nitric Oxide In Cancer: Reversal Of Drug/Immune Resistance
by: Benjamin Bonavida
Published: (2015-08-01)

Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter
by: Hai-Ling Gao, et al.
Published: (2020-10-01)

HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backbone.
by: Michelle Bronze, et al.
Published: (2012-01-01)

Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer
by: Fang-Fei Qian, et al.
Published: (2020-10-01)

Targeting Nrf2 may reverse the drug resistance in ovarian cancer
by: Danjie Li, et al.
Published: (2021-02-01)

Ferroptosis in cancer therapy: a novel approach to reversing drug resistance
by: Chen Zhang, et al.
Published: (2022-02-01)

Silencing of the ARK5 gene reverses the drug resistance of multidrug-resistant SGC7901/DDP gastric cancer cells
by: Hongtao Wan, et al.
Published: (2020-08-01)

The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines
by: Annalisa Schirizzi, et al.
Published: (2023-02-01)

E3 Ubiquitin Ligase Cbl-b Prevents Tumor Metastasis by Maintaining the Epithelial Phenotype in Multiple Drug-Resistant Gastric and Breast Cancer Cells
by: Ling Xu, et al.
Published: (2017-04-01)